About Nora Therapeutics
Nora Therapeutics is a company based in Palo Alto (United States) founded in 2007. Nora Therapeutics has raised $37.81 million across 5 funding rounds from investors including Burrill and Company, Prospect Venture Partners and Rho Capital Partners. Nora Therapeutics operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Gameto, among others.
- Headquarter Palo Alto, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.81 M (USD)
in 5 rounds
-
Latest Funding Round
$1 M (USD), Series B
Oct 13, 2015
-
Investors
Burrill and Company
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nora Therapeutics
Nora Therapeutics has successfully raised a total of $37.81M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $1 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nora Therapeutics
Nora Therapeutics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Burrill and Company, Prospect Venture Partners and Rho Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in US life sciences and healthtech firms.
|
Locked | Locked | Locked | |
|
Early-stage tech startups are invested in by Rho Capital Partners.
|
Locked | Locked | Locked | |
|
Venture capital and private equity firm
|
Locked | Locked | Locked |
Investor details for Nora Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nora Therapeutics
Investment portfolio details for Nora Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nora Therapeutics
Detailed financials for Nora Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nora Therapeutics Comparisons
Peer comparison for Nora Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nora Therapeutics
Nora Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Gameto, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| Locked | Locked | Locked |
Therapeutics for fertility and menopause treatments are developed.
|
|
| Locked | Locked | Locked |
Women care medicines are manufactured by Naari in India.
|
Detailed competitors of Nora Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nora Therapeutics
Complete news archive for Nora Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nora Therapeutics
Nora Therapeutics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Nora Therapeutics is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Nora Therapeutics is a funded company, having raised a total of $37.81M across 5 funding rounds to date.
Developer of therapeutics to address IVF failure and recurrent pregnancy loss. Its product includes NT100 (a proprietary recombinant form of human granulocyte colony-stimulating factor (G-CSF), a biologic agent similar to a naturally occurring protein in the female reproductive tract that may reduce the risk of miscarriage by optimizing maternal-fetal immune tolerance in women who have a history of unexplained recurrent miscarriage.
Nora Therapeutics's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Nora Therapeutics has 5 investors. Key investors include Burrill and Company, Prospect Venture Partners, Rho Capital Partners, Vivo Capital, and Novo Holdings.